Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion

Katsuyuki Yokoi, Yoko Nakajima, Tamae Ohye, Hidehito Inagaki, Yoshinao Wada, Tokiko Fukuda, Hideo Sugie, Isao Yuasa, Tetsuya Ito, Hiroki Kurahashi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in thePGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient’s phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.

Original languageEnglish
Title of host publicationJIMD Reports
PublisherSpringer
Pages85-90
Number of pages6
DOIs
Publication statusPublished - 01-01-2019

Publication series

NameJIMD Reports
Volume43
ISSN (Print)2192-8304
ISSN (Electronic)2192-8312

Fingerprint

Phosphoglucomutase
Genes
Mutation
Congenital Disorders of Glycosylation
Glycogen Storage Disease
Karyotyping
Initiator Codon
Cleft Palate
Creatine Kinase
Transaminases
Fluorescence In Situ Hybridization
Hypoglycemia
Glycosylation
Introns
Exons
Parents
Glycogen Storage Disease XIV
Phenotype
Muscles
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Cite this

Yokoi, Katsuyuki ; Nakajima, Yoko ; Ohye, Tamae ; Inagaki, Hidehito ; Wada, Yoshinao ; Fukuda, Tokiko ; Sugie, Hideo ; Yuasa, Isao ; Ito, Tetsuya ; Kurahashi, Hiroki. / Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion. JIMD Reports. Springer, 2019. pp. 85-90 (JIMD Reports).
@inbook{3923011e9c22452880b6b22fc7bfac2f,
title = "Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion",
abstract = "Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in thePGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient’s phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.",
author = "Katsuyuki Yokoi and Yoko Nakajima and Tamae Ohye and Hidehito Inagaki and Yoshinao Wada and Tokiko Fukuda and Hideo Sugie and Isao Yuasa and Tetsuya Ito and Hiroki Kurahashi",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/8904_2018_108",
language = "English",
series = "JIMD Reports",
publisher = "Springer",
pages = "85--90",
booktitle = "JIMD Reports",

}

Yokoi, K, Nakajima, Y, Ohye, T, Inagaki, H, Wada, Y, Fukuda, T, Sugie, H, Yuasa, I, Ito, T & Kurahashi, H 2019, Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion. in JIMD Reports. JIMD Reports, vol. 43, Springer, pp. 85-90. https://doi.org/10.1007/8904_2018_108

Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion. / Yokoi, Katsuyuki; Nakajima, Yoko; Ohye, Tamae; Inagaki, Hidehito; Wada, Yoshinao; Fukuda, Tokiko; Sugie, Hideo; Yuasa, Isao; Ito, Tetsuya; Kurahashi, Hiroki.

JIMD Reports. Springer, 2019. p. 85-90 (JIMD Reports; Vol. 43).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Disruption of the responsible gene in a phosphoglucomutase 1 deficiency patient by homozygous chromosomal inversion

AU - Yokoi, Katsuyuki

AU - Nakajima, Yoko

AU - Ohye, Tamae

AU - Inagaki, Hidehito

AU - Wada, Yoshinao

AU - Fukuda, Tokiko

AU - Sugie, Hideo

AU - Yuasa, Isao

AU - Ito, Tetsuya

AU - Kurahashi, Hiroki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in thePGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient’s phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.

AB - Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in thePGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient’s phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.

UR - http://www.scopus.com/inward/record.url?scp=85061138835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061138835&partnerID=8YFLogxK

U2 - 10.1007/8904_2018_108

DO - 10.1007/8904_2018_108

M3 - Chapter

AN - SCOPUS:85061138835

T3 - JIMD Reports

SP - 85

EP - 90

BT - JIMD Reports

PB - Springer

ER -